TF and cancer: In cancer multiple oncogenic events including activation of proto-oncogenes KRAS [55], EGFR, and inactivation of tumor suppressor genes such as P53 and PTEN, promote TF expression and contribute to other procoagulant changes in the tumor microenvironment [56].